MATHAI MAMMEN
Johnson & Johnson says booster dose increased antibodies in early-stage studiesA second dose of the J&J single-dose vaccine resulted in binding antibody levels nine times higher than the levels 28 days after people rec...
J&J's COVID-19 vaccine shows promise against Delta variantFirst identified in India, Delta is becoming the globally dominant variant of the coronavirus, according to the World Health Organization.
Johnson & Johnson testing vaccine on teensJ&J says the first teens are being enrolled in the United Kingdom and Spain. Teens in the United States, Canada and the Netherlands will be...
Second Covid-19 stage three vaccine trial paused within 24 hours over safety concernsUS pharmaceutical firm Eli Lilly on Tuesday suspended its Phase 3 trial of its lab-produced antibody treatment in hospitalized patients ove...
Pharma sector needs global collaboration: Industry leaders, government officialsAhead of the 14th edition of the annual BioPharma and Healthcare Summit, that bring stakeholders from India and the United States on one pl...
Load More